HERBALIFE LTD.
HERBALIFE LTD.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 371 | 451 | 353 | 306 | 321 | 329 | 415 | 403 | 374 | 398 | 575 | 496 | |||||
Receivables Net Current | 116 | 106 | 92 | 98 | 96 | 90 | 69 | 82 | 83 | 88 | 81 | 80 | |||||
Inventory Net | 508 | 495 | 512 | 513 | 513 | 488 | 475 | 515 | 481 | 502 | 505 | 497 | |||||
Prepaid Expense And Other Assets Current | 175 | 200 | 188 | 190 | 173 | 187 | 184 | 245 | 276 | 238 | 238 | 274 | |||||
Assets Current | 1,169 | 1,252 | 1,145 | 1,106 | 1,103 | 1,094 | 1,144 | 1,245 | 1,214 | 1,226 | 1,399 | 1,346 | |||||
Property Plant And Equipment Net | 413 | 429 | 448 | 457 | 466 | 450 | 460 | 463 | 468 | 511 | 507 | 492 | |||||
Operating Lease Right Of Use Asset | 167 | 169 | 168 | 172 | 182 | 184 | 186 | 188 | 188 | 179 | 186 | 191 | |||||
Intangible Assets Net Excluding Goodwill | 333 | 315 | 315 | 316 | 317 | 312 | 312 | 313 | 313 | 314 | 314 | 314 | |||||
Goodwill | 126 | 99 | 101 | 101 | 101 | 89 | 88 | 93 | 92 | 94 | 95 | 93 | |||||
Deferred Income Tax Assets Net | 479 | 464 | 464 | 402 | 428 | 414 | 399 | - | - | - | 179 | - | |||||
Other Assets Noncurrent | 172 | 147 | 145 | 144 | 140 | 141 | 140 | 352 | 327 | 323 | 129 | 288 | |||||
Assets | 2,858 | 2,875 | 2,786 | 2,697 | 2,736 | 2,684 | 2,728 | 2,654 | 2,602 | 2,647 | 2,809 | 2,725 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 101 | 88 | 100 | 88 | 92 | 85 | 70 | 87 | 81 | 90 | 84 | 78 | |||||
Member Compensation Liabilities | - | - | - | - | - | - | 26 | - | - | - | - | - | |||||
Long Term Debt Current | 12 | 9 | 21 | 21 | 168 | 219 | 284 | 283 | 22 | 3 | 310 | 233 | |||||
Other Liabilities Current | 482 | 564 | 490 | 545 | 506 | 519 | 517 | 583 | 557 | 539 | 541 | 520 | |||||
Liabilities Current | 974 | 1,022 | 1,013 | 1,000 | 1,094 | 1,129 | 1,230 | 1,285 | 976 | 945 | 1,278 | 1,165 | |||||
Long Term Debt Noncurrent | 2,004 | 1,982 | 1,972 | 1,997 | 1,974 | 1,975 | 1,977 | 1,978 | 2,321 | 2,405 | 2,253 | 2,319 | |||||
Operating Lease Liability Noncurrent | 152 | 155 | 156 | 157 | 165 | 167 | 170 | 167 | 173 | 164 | 168 | 174 | |||||
Other Liabilities Noncurrent | 195 | 150 | 155 | 149 | 157 | 149 | 153 | 178 | 169 | 170 | 172 | 170 | |||||
Liabilities | 3,325 | 3,309 | 3,295 | 3,303 | 3,391 | 3,420 | 3,529 | 3,608 | 3,639 | 3,684 | 3,870 | 3,828 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 335 | 334 | 316 | 305 | 294 | 288 | 278 | 267 | 253 | 244 | 234 | 222 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -265 | -258 | -252 | -252 | -247 | -266 | -271 | -235 | -257 | -243 | -232 | -253 | |||||
Retained Earnings Accumulated Deficit | -544 | -518 | -580 | -665 | -708 | -758 | -808 | -986 | -1,033 | -1,038 | -1,062 | -1,073 | |||||
Stockholders Equity | -467 | -442 | -515 | -612 | -654 | -736 | -801 | -954 | -1,037 | -1,037 | -1,060 | -1,104 | |||||
Minority Interest | 8 | 7 | 6 | 6 | 6 | - | 0 | - | - | - | - | - | |||||
Liabilities And Stockholders Equity | 2,858 | 2,875 | 2,786 | 2,697 | 2,736 | 2,684 | 2,728 | 2,654 | 2,602 | 2,647 | 2,809 | 2,725 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | |||||
Shares Outstanding | 105 | 103 | 103 | 103 | 103 | 102 | 101 | 101 | 101 | 100 | 99 | 99 | |||||
Common Stock Shares Issued | 105 | 103 | 103 | - | - | - | 101 | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -27.25% | -23.72% | -27.68% | - | - | - | - | - | - | - | - | - |
| 2025 | -7.50% | 11.67% | 28.75% | 5.73% | -4.11% | -9.84% | 54.49% | 61.77% | 101.94% | -6.95% | -7.92% | -13.48% |
| 2024 | 23.85% | 28.80% | 28.69% | -29.56% | -41.21% | -43.00% | 23.64% | -4.85% | -3.52% | 43.24% | 19.04% | 19.75% |
| 2023 | - | - | - | - | - | - | -7.76% | 8.34% | -10.78% | -21.70% | -33.11% | -18.47% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.20 | 1.23 | 1.13 | 1.11 | 1.01 | 0.97 | 0.93 | 0.97 | 1.24 | 1.30 | 1.10 | 1.16 | |||||
| Quick Ratio | 0.50 | 0.55 | 0.44 | 0.40 | 0.38 | 0.37 | 0.39 | 0.38 | 0.47 | 0.51 | 0.51 | 0.49 | |||||
| Working Capital | 195.30M | 230.00M | 131.80M | 106.30M | 8.60M | -35.00M | -86.70M | -40.40M | 237.60M | 281.50M | 121.70M | 180.70M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -7.12 | -7.50 | -6.47 | -5.40 | -5.18 | -4.65 | -4.41 | -3.78 | -3.51 | -3.55 | -3.65 | -3.47 | |||||
| Interest Coverage TTM | 2.55 | 2.37 | 2.24 | 2.19 | 2.14 | 1.88 | 1.77 | 1.66 | 1.71 | 2.18 | 2.15 | 2.44 | |||||
| Debt Ratio | 1.16 | 1.15 | 1.18 | 1.22 | 1.24 | 1.27 | 1.29 | 1.36 | 1.40 | 1.39 | 1.38 | 1.40 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.86 | 1.85 | 1.83 | 1.85 | 1.85 | 1.86 | 1.80 | 1.86 | 1.88 | 1.90 | 1.83 | 1.85 | |||||
| Days Sales Outstanding TTM | 7.44 | 6.97 | 5.83 | 6.61 | 6.63 | 6.56 | 5.49 | 5.89 | 6.12 | 6.22 | 5.47 | 5.97 | |||||
| Receivables Turnover TTM | 49.04 | 52.35 | 62.66 | 55.19 | 55.07 | 55.62 | 66.53 | 61.93 | 59.63 | 58.67 | 66.70 | 61.13 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 1.57 | 2.21 | 2.20 | 3.08 | 3.15 | 2.74 | 2.50 | 0.85 | 0.81 | 1.36 | 1.42 | 1.86 | |||||
| Free Cash Flow Per Share TTM | 3.08 | 3.60 | 2.46 | 2.10 | 1.67 | 1.62 | 1.62 | 1.79 | 1.55 | 1.88 | 2.25 | 1.74 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 77.70% | 77.78% | 77.87% | 77.96% | 78.12% | 78.09% | 77.88% | 77.52% | 77.01% | 76.80% | 76.47% | 76.75% | |||||
| Operating Profit Margin TTM | 9.47% | 9.67% | 9.55% | 9.83% | 9.92% | 8.82% | 7.73% | 6.70% | 6.24% | 7.05% | 7.04% | 7.75% | |||||
| Net Profit Margin TTM | 3.15% | 4.66% | 4.53% | 6.46% | 6.59% | 5.66% | 5.09% | 1.73% | 1.63% | 2.70% | 2.81% | 3.71% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 5.52% | 3.69% | 0.89% | -0.78% | -2.25% | -2.45% | -1.37% | -0.55% | -0.01% | -0.90% | -2.73% | -5.87% | |||||
| Net Income Growth (1Y) | -49.65% | -14.73% | -10.22% | 270.21% | 296.22% | 104.37% | 78.83% | -53.54% | -63.68% | -45.64% | -55.74% | -38.91% | |||||
| EPS Growth (1Y) | -50.51% | -16.62% | -12.15% | 261.61% | 288.12% | 100.75% | 75.99% | -54.32% | -64.23% | -46.30% | -55.97% | -39.64% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 8.40 | 6.39 | 5.80 | 2.72 | 2.72 | 3.12 | 2.65 | 8.38 | 12.75 | 7.30 | 10.62 | 7.45 | |||||
| P/B TTM | -2.94 | -3.46 | -2.60 | -1.42 | -1.35 | -1.19 | -0.84 | -0.76 | -1.01 | -0.97 | -1.42 | -1.26 | |||||
| P/S TTM | 0.26 | 0.30 | 0.26 | 0.18 | 0.18 | 0.18 | 0.13 | 0.15 | 0.21 | 0.20 | 0.30 | 0.28 | |||||
| Market Cap | 1.37B | 1.53B | 1.33B | 871.85M | 885.27M | 875.95M | 673.01M | 725.47M | 1.05B | 1.00B | 1.51B | 1.39B | |||||
| Enterprise Value | 3.00B | 3.05B | 2.94B | 2.56B | 2.68B | 2.72B | 2.50B | 2.57B | 3.00B | 3.00B | 3.48B | 3.42B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 322.30M | 373.90M | 252.90M | 217.00M | 171.40M | 164.40M | 163.40M | 180.30M | 156.40M | 187.50M | 222.50M | 172.50M | |||||
| Net Debt | 1.62B | 1.52B | 1.62B | 1.69B | 1.80B | 1.84B | 1.82B | 1.84B | 1.95B | 2.00B | 1.97B | 2.04B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
HERBALIFE LTD. (HLF) — SEC Financial Statements & Analysis
HERBALIFE LTD. (HLF) is a wholesale-drugs, proprietaries & druggists' sundries company, incorporated in E9. HERBALIFE LTD. trades on NYSE as: HLF. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), HERBALIFE LTD. reported a 5.52% year-over-year revenue growth, a Gross Profit Margin of 77.70% (TTM), a Debt-to-Equity ratio of -7.12x, a Price-to-Sales (P/S) ratio of 0.26x (TTM), a Price-to-Book (P/B) ratio of -2.94x (TTM), at a market cap of $1.37B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 5.52%
- Gross Profit Margin TTM
- 77.70%
- Debt To Equity
- -7.12x
- P/S TTM
- 0.26x
- P/B TTM
- -2.94x
- Market Cap
- $1.37B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HERBALIFE LTD. in?
HERBALIFE LTD. (HLF) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry.
What is HLF's market cap?
HERBALIFE LTD. (HLF) has a market capitalization of $1.37B as of 2026-06-30.
What is HLF's P/E ratio?
HERBALIFE LTD. (HLF)'s trailing twelve month P/E ratio is 8.40x as of 2026-06-30.
What exchange does HLF trade on?
HERBALIFE LTD. (HLF) trades on the NYSE.
Where is HERBALIFE LTD. incorporated?
HERBALIFE LTD. is incorporated in Cayman Islands.